Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Embryonal Tumor, NOS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02611024
What this trial is testing

Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors

Who this might be right for
Advanced Solid TumorsGlioblastomaSoft Tissue Sarcoma (Excluding GIST)+9 more
PharmaMar 316
Not applicableStudy completedNCT01365962
What this trial is testing

Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma

Who this might be right for
Sarcoma
Children's Oncology Group 60
Not applicableLooking for participantsNCT05982691
What this trial is testing

Development of Asian Consortium for Data Collection and Clinical Trial of CNS Tumors

Who this might be right for
CNS GerminomaCNS TumorAsian Consortium
National Cancer Center, Korea 400
Early research (Phase 1)Ended earlyNCT06193174
What this trial is testing

Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1)

Who this might be right for
Recurrent Malignant GliomaGlioblastoma Multiforme of BrainGliosarcoma of Brain+1 more
University of Alabama at Birmingham 1
Testing effectiveness (Phase 2)Study completedNCT00137774
What this trial is testing

Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Dana-Farber Cancer Institute 34
Testing effectiveness (Phase 2)Study completedNCT00004017
What this trial is testing

Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma

Who this might be right for
Brain and Central Nervous System Tumors
Peregrine Pharmaceuticals 60
Early research (Phase 1)Study completedNCT00049023
What this trial is testing

Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell Tumor+4 more
O'Dorisio, M S 27
Not applicableWithdrawnNCT04432532
What this trial is testing

Neuroendocrine and Adrenal Tumors

Who this might be right for
Neuroendocrine TumorsAdrenal Tumor
University of Pennsylvania
Testing effectiveness (Phase 2)Active Not RecruitingNCT04969887
What this trial is testing

Combination Immunotherapy in Rare Cancers Under InvesTigation

Who this might be right for
Advanced Biliary Tract CancerNeuroendocrine TumorsFemale Reproductive System Neoplasm+1 more
Olivia Newton-John Cancer Research Institute 240
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Early research (Phase 1)Active Not RecruitingNCT03212404
What this trial is testing

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell LungCarcinoma, Small Cell+10 more
Checkpoint Therapeutics, Inc. 272
Not applicableStudy completedNCT00828516
What this trial is testing

Using Traditional Acupuncture in the Management of Cancer Treatment Related Lymphoedema

Who this might be right for
Breast CancerHead and Neck CancerLymphedema
East and North Hertfordshire NHS Trust 56
Testing effectiveness (Phase 2)Ended earlyNCT02375984
What this trial is testing

A Study Using Tumor-Reactive Autologous Tumor Infiltrating Lymphocytes (TIL) in Metastatic Melanomas

Who this might be right for
Metastatic Melanoma
Saint John's Cancer Institute 1
Not applicableLooking for participantsNCT05867004
What this trial is testing

Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma

Who this might be right for
MelanomaImmune DefectTumor Skin
Institut Claudius Regaud 100
Early research (Phase 1)Ended earlyNCT01902771
What this trial is testing

Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors

Who this might be right for
GliomaBrain CancerBrain Tumor+2 more
Edward Ziga 1
Not applicableUnknownNCT01798771
What this trial is testing

Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery

Who this might be right for
Primary Malignant Neoplasm of Nervous SystemGliomaGlioblastoma+1 more
Johann Wolfgang Goethe University Hospital 108
Testing effectiveness (Phase 2)Ended earlyNCT03645928
What this trial is testing

Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

Who this might be right for
Metastatic MelanomaSquamous Cell Carcinoma of the Head and NeckNon-small Cell Lung Cancer
Iovance Biotherapeutics, Inc. 225
Early research (Phase 1)Ended earlyNCT04258592
What this trial is testing

18F-MFBG PET Imaging of the Norepinephrine Transporter in Neural Crest and Neuroendocrine Tumors

Who this might be right for
Neural Crest TumorNeuroendocrine Tumors
Universitaire Ziekenhuizen KU Leuven 6
Testing effectiveness (Phase 2)UnknownNCT00604136
What this trial is testing

Treatment of Metastatic Melanoma With Tumor Infiltrating Lymphocytes and IL-2 Following Lympho-depleting Chemotherapy

Who this might be right for
Metastatic Melanoma
Hadassah Medical Organization 20
Testing effectiveness (Phase 2)Study completedNCT00204633
What this trial is testing

Darbepoetin Alfa in Patients With "Poor Prognosis" Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP)

Who this might be right for
Dysgerminoma
University Hospital Tuebingen 108
Next Page